Skip to main content

Bexar County Opioid Lawsuit Gets 2020 Trial Dates

Bexar County Opioid Lawsuit Gets 2020 Trial Dates

Bexar County Opioid Lawsuit Gets 2020 Trial Dates

Introduction

On Tuesday, a Texas Judge announced that the Opioid lawsuits brought by Dallas and Bexar Counties in the state consolidated MDL, alleging that the opioid makers and distributors made false and misleading statements about drugs, will face their first trials in October 2020. The announcement followed a decision on Friday by Judge Robert Schaffer, who is overseeing the MDL in Texas that Dallas’ lawsuits will be the first bellwether to go to trial.  

Bexar County Judge Nelson Wolff stated that the trial date is a major milestone in litigation and Bexar County will become the site for the first wave of trials in the MDL. The judge also stated that Bexar County was the first in the area to have recognized this epidemic and has been a leader in developing a task force to tackle this problem.

According to a statement by counsel Martin J. Phipps of Phipps Deacon Purnell PLLC, Bexar County is seeking $1B in damages, a conservative estimate of the costs borne by taxpayers. Phipps also stated that the pharmaceutical companies mislead patients, regulators, and physicians about the risks and benefits of opioids to treat pain.

U.S. District Judge Dan Polster is presiding over all opioid lawsuits consolidated under MDL No. 2804 (In Re: National Prescription Opiate Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!